Abstract
Retinopathy of prematurity (ROP) is a relatively new condition. Only in the last 60 years have children survived who were born prematurely enough to have a significantly immature retinal vasculature. This article describes the classification and physiology of ROP, the interventions now available, and possible future therapies.
MeSH terms
-
Endothelial Growth Factors / physiology
-
Humans
-
Infant, Newborn
-
Infant, Premature
-
Intercellular Signaling Peptides and Proteins / physiology
-
Lymphokines / physiology
-
Mass Screening
-
Retinopathy of Prematurity* / diagnosis
-
Retinopathy of Prematurity* / epidemiology
-
Retinopathy of Prematurity* / therapy
-
Risk Factors
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
Substances
-
Endothelial Growth Factors
-
Intercellular Signaling Peptides and Proteins
-
Lymphokines
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors